Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00605_DB00945> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00605_DB00945 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00605_DB00945 label "DDI between Sulindac and Acetylsalicylic acid - Risk of additive toxicity (e.g. bleed risk). Acetylsalicylic acid may decrease the serum concentration of sulindac. Sulindac may counteract the cardioprotective effects of acetylsalicylic acid. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of both agents if the interacting agent is initiated, discontinued or dose changed. [drugbank_resource:DB00605_DB00945]" assertion.
- drugbank_resource:DB00605_DB00945 identifier "drugbank_resource:DB00605_DB00945" assertion.
- drugbank_resource:DB00605_DB00945 title "DDI between Sulindac and Acetylsalicylic acid - Risk of additive toxicity (e.g. bleed risk). Acetylsalicylic acid may decrease the serum concentration of sulindac. Sulindac may counteract the cardioprotective effects of acetylsalicylic acid. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of both agents if the interacting agent is initiated, discontinued or dose changed." assertion.